CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Alamar Biosciences, Inc.

ALMR
$1.58B
Small Cap
NASDAQLaboratory Analytical Instruments🇺🇸North AmericaFREMONT222 employees

Drugs in Pipeline

0

Phase 3 Programs

0

Upcoming Catalysts

0

Next Catalyst

None scheduled

Market Overview

Stock performance and key metrics

ALMR News
Catalyst Timeline

0 upcoming, 1 past

No catalysts found.

Drug Pipeline

No drugs found in this phase.

Market-Implied Move
Regulatory Approvals

Frequently asked questions

When is Alamar Biosciences, Inc.'s next FDA catalyst?

CatalystAlert tracks every upcoming catalyst for Alamar Biosciences, Inc. (ALMR) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.

How do I track ALMR biotech catalysts?

Add ALMR to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Alamar Biosciences, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.

Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply